Related Experiment Video

Updated: Mar 5, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

A Comprehensive List of Items to be Included on a Pediatric Drug Monograph

Lauren E Kelly, Shinya Ito, David Woods

    The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
    |March 25, 2017
    PubMed

    Insights

    Healthcare providers identified 116 essential items for pediatric drug monographs. This consensus-based list will standardize international pediatric formulary development and improve medication safety for children.

    Area of Science:

    • Pediatric pharmacology
    • Drug information science

    Background:

    • Children require specialized drug information for safe prescribing.
    • Pediatric drug monographs are crucial for effective medication use in children.
    • Current knowledge on information needs for pediatric drug monographs is limited.

    Purpose of the Study:

    • To identify key information items for pediatric drug monographs.
    • To establish a consensus-based list of essential monograph components.

    Main Methods:

    • An expert steering committee and environmental scan were established.
    • A 2-round Delphi survey was conducted with 46 international participants.
    • An international consensus meeting finalized the list of monograph items.

    Main Results:

    • Pediatric formularies are the primary resource for medication information in children.
    • 116 important items were identified for comprehensive pediatric drug monographs.
    • Key items include general information, adverse reactions, dosages, precautions, drug interactions, formulation, and drug properties.

    Conclusions:

    • International consensus identified 116 critical items for pediatric drug monographs.
    • This list will aid in developing standardized pediatric drug monographs globally.
    • The findings support international formulary development for pediatric medication safety.
    Abstract

    Keywords:
    drug monographdrug safetyformularypediatricsprescribingtherapeutics

    More Related Videos

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies09:30

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    4.6K
    Guidelines for Elective Pediatric Fiberoptic Intubation11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    18.8K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    342
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    555
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    503
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    398
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    303
    Dosage Regimens: Designs and Approaches01:28

    Dosage Regimens: Designs and Approaches

    Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
    406